Organization
Astellas (China) Investment Co., Ltd
1 abstract
Abstract
EV-203: Phase 2 trial of enfortumab vedotin in patients with previously treated advanced urothelial carcinoma in China.Org: Astellas (China) Investment Co., Ltd, Seagen, Bothell, WA, Astellas Pharma, Inc., Astellas Pharma Inc.,